Literature DB >> 29362966

Fusion imaging with contrast-enhanced ultrasonography for evaluating the early therapeutic efficacy of radiofrequency ablation for small hypervascular hepatocellular carcinomas with iso-echoic or unclear margins on conventional ultrasonography.

Shuhei Nishigori1, Kazushi Numata2, Kuniyasu Irie1, Hiroyuki Fukuda1, Makoto Chuma1, Shin Maeda3.   

Abstract

PURPOSE: We evaluated the efficacy of fusion imaging combining contrast-enhanced ultrasonography (CEUS) images and arterial phase contrast-enhanced CT (CECT) or hepatobiliary phase magnetic resonance imaging with gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (EOB-MRI) images for the early evaluation of the effectiveness of radiofrequency ablation (RFA) for small hypervascular hepatocellular carcinoma (HCC) with iso-echoic or unclear margins on conventional US.
METHODS: Forty HCCs (22 iso-echoic and 18 unclear margin lesions) with mean diameters of 13.7 mm were treated using RFA under the guidance of fusion imaging with CEUS. The adequacy of RFA was evaluated using fusion imaging with CEUS 1 day after RFA. CECT or EOB-MRI was performed 1 month after RFA. We reviewed the images obtained using both modalities.
RESULTS: When the 1-month CECT or EOB-MRI scans were used as the reference standard, the sensitivity, specificity, and accuracy of the 1-day fusion imaging for the diagnosis of the adequate ablation of these HCCs were 97, 100, and 98%, respectively; the kappa value for the agreement between the findings using the two modalities was 0.655.
CONCLUSION: Fusion imaging with CEUS appears to be a useful method for the early evaluation of the efficacy of RFA for the treatment of HCCs with iso-echoic or unclear margins on conventional US.

Entities:  

Keywords:  Contrast-enhanced ultrasonography; Fusion imaging; Hepatocellular carcinoma; Radiofrequency ablation

Mesh:

Substances:

Year:  2018        PMID: 29362966     DOI: 10.1007/s10396-018-0861-6

Source DB:  PubMed          Journal:  J Med Ultrason (2001)        ISSN: 1346-4523            Impact factor:   1.314


  38 in total

1.  Advances in ultrasound systems for hepatic lesions in Japan.

Authors:  Kazushi Numata
Journal:  J Med Ultrason (2001)       Date:  2015-07       Impact factor: 1.314

Review 2.  Image-guided tumor ablation: standardization of terminology and reporting criteria.

Authors:  S Nahum Goldberg; Clement J Grassi; John F Cardella; J William Charboneau; Gerald D Dodd; Damian E Dupuy; Debra Gervais; Alice R Gillams; Robert A Kane; Fred T Lee; Tito Livraghi; John McGahan; David A Phillips; Hyunchul Rhim; Stuart G Silverman
Journal:  Radiology       Date:  2005-04-21       Impact factor: 11.105

3.  Use of vessel patterns on contrast-enhanced ultrasonography using a perflubutane-based contrast agent for the differential diagnosis of regenerative nodules from early hepatocellular carcinoma or high-grade dysplastic nodules in patients with chronic liver disease.

Authors:  Kazushi Numata; Hiroyuki Fukuda; Hiromi Nihonmatsu; Masaaki Kondo; Akito Nozaki; Makoto Chuma; Manabu Morimoto; Takashi Oshima; Masahiro Okada; Takamichi Murakami; Shigeo Takebayashi; Shin Maeda; Yoshiaki Inayama; Masayuki Nakano; Katsuaki Tanaka
Journal:  Abdom Imaging       Date:  2015-10

4.  Newly developed novel ultrasound technique, defect reperfusion ultrasound imaging, using sonazoid in the management of hepatocellular carcinoma.

Authors:  Masatoshi Kudo; Kinuyo Hatanaka; Kiyoshi Maekawa
Journal:  Oncology       Date:  2010-07-08       Impact factor: 2.935

5.  Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma.

Authors:  Kazushi Numata; Hiroyuki Fukuda; Manabu Morimoto; Masaaki Kondo; Akito Nozaki; Takashi Oshima; Masahiro Okada; Shigeo Takebayashi; Shin Maeda; Katsuaki Tanaka
Journal:  Eur J Radiol       Date:  2011-12-23       Impact factor: 3.528

6.  One-month apparent diffusion coefficient correlates with response to radiofrequency ablation of hepatocellular carcinoma.

Authors:  Maxime Barat; Audrey Fohlen; Christophe Cassinotto; Anne Sophie Jannot; Raphael Dautry; Jean-Pierre Pelage; Mourad Boudiaf; Marc Pocard; Clarisse Eveno; Bachir Taouli; Philippe Soyer; Anthony Dohan
Journal:  J Magn Reson Imaging       Date:  2016-10-20       Impact factor: 4.813

Review 7.  Hepatocellular carcinoma: current management and recent advances.

Authors:  Wan-Yee Lau; Eric C H Lai
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2008-06

8.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

9.  Radiofrequency ablation of very-early-stage hepatocellular carcinoma inconspicuous on fusion imaging with B-mode US: value of fusion imaging with contrast-enhanced US.

Authors:  Ji Hye Min; Hyo Keun Lim; Sanghyeok Lim; Tae Wook Kang; Kyoung Doo Song; Seo-Youn Choi; Hyunchul Rhim; Min Woo Lee
Journal:  Clin Mol Hepatol       Date:  2014-03-26

10.  Rate of local tumor progression following radiofrequency ablation of pathologically early hepatocellular carcinoma.

Authors:  Yoshiteru Hao; Kazushi Numata; Tomohiro Ishii; Hiroyuki Fukuda; Shin Maeda; Masayuki Nakano; Katsuaki Tanaka
Journal:  World J Gastroenterol       Date:  2017-05-07       Impact factor: 5.742

View more
  6 in total

1.  Real-time fusion-imaging in low back pain: a new navigation system for facet joint injections.

Authors:  Elena Massone; Davide Orlandi; Alberto Bellelli; Fabio Martino; Luca Cavagnaro; Matteo Formica; Pietro Caruso; Enzo Silvestri
Journal:  Radiol Med       Date:  2018-07-03       Impact factor: 3.469

Review 2.  Application of new ultrasound techniques for focal liver lesions.

Authors:  Feiqian Wang; Kazushi Numata; Hiromi Nihonmatsu; Masahiro Okada; Shin Maeda
Journal:  J Med Ultrason (2001)       Date:  2020-01-16       Impact factor: 1.314

3.  Application and Evaluation of a 64-Slice CT Three-Dimensional Fusion Technique in the Determination of the Effective Ablation Margin after Radiofrequency Ablation of Hepatocellular Carcinoma.

Authors:  Haihao Du; Xiongmu Tan; Liuhui Cheng; Baopeng Zhang; Daoqing Wang
Journal:  Comput Math Methods Med       Date:  2022-01-27       Impact factor: 2.238

4.  Clinical application of contrast-enhanced ultrasound after percutaneous renal tumor ablation.

Authors:  Fang Guo; Bing Hu; Lei Chen; Jia Li
Journal:  Br J Radiol       Date:  2019-10-01       Impact factor: 3.039

5.  Comparison of Sonazoid contrast-enhanced ultrasound and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid MRI for the histological diagnosis of hepatocellular carcinoma.

Authors:  Feiqian Wang; Kazushi Numata; Masahiro Okada; Makoto Chuma; Hiromi Nihonmatsu; Satoshi Moriya; Akito Nozaki; Katsuaki Ogushi; Wen Luo; Litao Ruan; Masayuki Nakano; Masako Otani; Yoshiaki Inayama; Shin Maeda
Journal:  Quant Imaging Med Surg       Date:  2021-06

6.  Use of Contrast-Enhanced Ultrasound with Sonazoid for Evaluating the Radiotherapy Efficacy for Hepatocellular Carcinoma.

Authors:  Akihiro Funaoka; Kazushi Numata; Atsuya Takeda; Yusuke Saigusa; Yuichirou Tsurugai; Hiromi Nihonmatsu; Makoto Chuma; Hiroyuki Fukuda; Masahiro Okada; Masayuki Nakano; Shin Maeda
Journal:  Diagnostics (Basel)       Date:  2021-03-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.